HK$5,180
Safe T21 Express (T21) Test adopts the latest and patented Non-Invasive Prenatal Testing (NIPT) technology for the screening of fetal chromosomal aneuploidies. The test utilizes Next Generation Sequencing followed by bioinformatics analysis on both maternal DNA and cell free placental DNA found in maternal blood. Compared to the traditional screening methods based on nuchal translucency or maternal age, it is more sensitive, reliable, accurate and informative.
Doctor Consultation
- Detail Medical History
- Systematic Review
- Family and Social History
The test screens for 14 validated conditions:
3 Trisomies:
- T21 (Down Syndrome)
- T18 (Edwards Syndrome)
- T13 (Patau Syndrome)
4 Sex Chromosome Aneuploidies:
- X0 Monosomy X (Turner Syndrome)
- XYY Syndrome (Jacob’s Syndrome)
- XXY Klinefelter Syndrome
- XXX Triple X Syndrome
Oral Glucose Tolerance Test
- Mothers can enjoy a free OGTT at 26–30 Gestational Weeks.
7 Microdeletion Syndromes
(>3Mb in size within the chromosomal regions responsible for):
- 1p36 Deletion Syndrome
- 1 Deletion Syndrome
- 5p Deletion/ Cri-du-chat Syndrome
- 1 Deletion/ Langer-Giedion Syndrome
- 2 Deletion/ Angelman Syndrome
- 2 Deletion/ Prader–Willi Syndrome
- 2 Deletion/ DiGeorge Syndrome